Persistent T Cell Immunity Following Nipah Virus Infection: Evidence From Malaysian Survivors

Puteri Ainaa S Ibrahim1, Hui Ming Ong1, Heng Choon Cheong1

  • 1Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.

PubMed

Insights

Nipah virus (NiV) survivors show durable T cell immunity 25 years post-infection. Persistent cellular responses, particularly to the NiV-G glycoprotein, were observed, offering insights for NiV vaccine development.

Area of Science:

  • Virology
  • Immunology
  • Neuroscience

Background:

  • Nipah virus (NiV) infection elicits robust humoral immunity.
  • The long-term durability of NiV-specific cellular immunity, particularly T cell responses, remains largely uncharacterized.
  • Understanding persistent immune memory is crucial for managing viral infections and developing effective vaccines.

Purpose of the Study:

  • To investigate the long-term durability of Nipah virus-specific T cell responses in survivors of the 1998 Malaysian outbreak.
  • To characterize the nature and magnitude of cellular immunity approximately 25 years after NiV infection.
  • To explore the correlation between T cell responses, neurological sequelae, and cognitive function in NiV survivors.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) were collected from four survivors of the 1998 NiV outbreak.
  • PBMCs were stimulated with overlapping peptide mini-pools covering NiV fusion (NiV-F) and attachment (NiV-G) glycoproteins.
  • T cell responses were quantified using ELISpot and intracellular cytokine staining (ICS) assays.

Main Results:

  • Durable, cytokine-producing T cell responses specific to NiV were detected up to 25 years post-infection.
  • Immunodominant T cell epitopes were identified within the ectodomain of the NiV-G glycoprotein.
  • Survivors with neurological sequelae demonstrated significantly stronger T cell responses and cognitive impairment compared to those without sequelae.

Conclusions:

  • Long-lasting cellular immunity against Nipah virus persists for decades after infection.
  • The NiV-G glycoprotein is a key target for durable T cell memory.
  • Persistent T cell responses are associated with neurological sequelae, suggesting a role in long-term pathology and highlighting the need for effective NiV vaccines.